At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Lepicol probiotic & prebiotic formula +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics
In Brief
A clinical study evaluating Lepicol probiotic & prebiotic formula and Simple lifestyle advice for Nonalcoholic Fatty Liver Disease. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The investigators' aim is to determine whether probiotic and prebiotic treatment plus lifestyle advice is more effective in reducing hepatic fat content than lifestyle advice alone in patients with Nonalcoholic Fatty Liver Disease (NAFLD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNonalcoholic Fatty Liver Disease
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedMar 2009
Primary CompletionJan 2012
TodayJul 2026
First PostedMar 26, 2009
Enrollment StartFeb 1, 2009
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 17.3 years ago
Interventions
Lepicol probiotic & prebiotic formuladrug
NAFLD patients treated with Lepicol probiotic and prebiotic formula for 24 weeks.
Simple lifestyle adviceother
NAFLD patients treated with lifestyle advice.